PVG Asset Management Corp Invests $398,000 in Grail, Inc. (NASDAQ:GRAL)

PVG Asset Management Corp acquired a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 22,287 shares of the company's stock, valued at approximately $398,000. Grail makes up 1.9% of PVG Asset Management Corp's holdings, making the stock its 21st largest position. PVG Asset Management Corp owned about 0.07% of Grail as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. Crcm LP bought a new position in Grail in the 4th quarter valued at approximately $65,061,000. Sessa Capital IM L.P. purchased a new position in shares of Grail in the fourth quarter worth about $53,550,000. Primecap Management Co. CA purchased a new position in shares of Grail in the fourth quarter worth about $37,118,000. Baker BROS. Advisors LP purchased a new position in Grail during the fourth quarter valued at approximately $29,098,000. Finally, Vanguard Group Inc. purchased a new position in Grail in the 4th quarter worth approximately $25,902,000.

Grail Trading Down 6.7%

Shares of GRAL stock traded down $2.74 on Friday, reaching $38.36. The company's stock had a trading volume of 727,479 shares, compared to its average volume of 1,252,513. The stock's fifty day simple moving average is $31.93 and its 200-day simple moving average is $28.16. Grail, Inc. has a 1 year low of $12.33 and a 1 year high of $63.99. The company has a market capitalization of $1.38 billion and a price-to-earnings ratio of -0.63.

Grail (NASDAQ:GRAL - Get Free Report) last posted its earnings results on Tuesday, May 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.03) by $0.93. The company had revenue of $31.84 million during the quarter, compared to analysts' expectations of $35.80 million. Equities research analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current year.

Analyst Ratings Changes

GRAL has been the subject of several research reports. Canaccord Genuity Group upped their price objective on shares of Grail from $32.00 to $43.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. Morgan Stanley raised their target price on shares of Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a report on Tuesday, March 18th.

Insider Buying and Selling at Grail

In related news, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $56,659.20. Following the transaction, the chief financial officer now owns 335,170 shares of the company's stock, valued at approximately $10,457,304. This represents a 0.54% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Robert P. Ragusa sold 7,625 shares of the stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.21, for a total value of $237,976.25. Following the transaction, the chief executive officer now directly owns 828,662 shares in the company, valued at approximately $25,862,541.02. The trade was a 0.91% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 194,948 shares of company stock worth $6,583,130 in the last three months. 1.85% of the stock is owned by corporate insiders.

Grail Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.